Insider Buying: Integer (NYSE:ITGR) Director Purchases 1,600 Shares of Stock

Integer Holdings Corporation (NYSE:ITGR) Director Cheryl Capps bought 1,600 shares of the business’s stock in a transaction that occurred on Thursday, November 6th. The shares were acquired at an average price of $66.70 per share, with a total value of $106,720.00. Following the transaction, the director directly owned 11,702 shares of the company’s stock, valued at $780,523.40. This represents a 15.84% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Integer Stock Up 1.5%

Shares of NYSE:ITGR opened at $69.29 on Monday. The company has a market cap of $2.43 billion, a price-to-earnings ratio of 28.86, a PEG ratio of 0.60 and a beta of 0.95. The company has a current ratio of 3.71, a quick ratio of 2.45 and a debt-to-equity ratio of 0.70. The company has a 50-day moving average price of $95.47 and a 200 day moving average price of $108.90. Integer Holdings Corporation has a 12 month low of $62.00 and a 12 month high of $146.36.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.During the same quarter last year, the company posted $1.43 earnings per share. Integer’s quarterly revenue was up 8.4% compared to the same quarter last year. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. As a group, equities research analysts predict that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Integer declared that its board has initiated a share buyback plan on Tuesday, November 4th that allows the company to buyback $200.00 million in outstanding shares. This buyback authorization allows the medical equipment provider to purchase up to 8.3% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s board believes its shares are undervalued.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Integer in a research report on Friday, October 31st. Argus cut shares of Integer from a “buy” rating to a “hold” rating in a research note on Friday, October 24th. Truist Financial dropped their price target on Integer from $121.00 to $88.00 and set a “buy” rating on the stock in a research note on Friday, October 24th. Piper Sandler reduced their price objective on Integer from $155.00 to $82.00 and set an “overweight” rating for the company in a research note on Friday, October 24th. Finally, Raymond James Financial reaffirmed an “outperform” rating and set a $95.00 target price (down previously from $143.00) on shares of Integer in a report on Friday, October 24th. Four equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, Integer currently has a consensus rating of “Hold” and an average price target of $96.75.

Hedge Funds Weigh In On Integer

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. CWM LLC increased its holdings in Integer by 46.1% in the 2nd quarter. CWM LLC now owns 355 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 112 shares during the period. Xponance Inc. boosted its stake in shares of Integer by 5.1% in the 1st quarter. Xponance Inc. now owns 2,518 shares of the medical equipment provider’s stock valued at $297,000 after purchasing an additional 122 shares in the last quarter. GAMMA Investing LLC increased its holdings in Integer by 20.2% during the 2nd quarter. GAMMA Investing LLC now owns 796 shares of the medical equipment provider’s stock valued at $98,000 after purchasing an additional 134 shares in the last quarter. Orion Porfolio Solutions LLC lifted its position in shares of Integer by 1.4% during the second quarter. Orion Porfolio Solutions LLC now owns 9,755 shares of the medical equipment provider’s stock worth $1,200,000 after purchasing an additional 138 shares in the last quarter. Finally, Ameritas Investment Partners Inc. raised its position in shares of Integer by 4.4% during the second quarter. Ameritas Investment Partners Inc. now owns 3,521 shares of the medical equipment provider’s stock worth $433,000 after acquiring an additional 148 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.